World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
27211
World Ranking
16996
National Ranking
890

Overview

Carola Berking is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, with a focus on oncology, epidemiology, dermatology, immunology, and molecular biology. Their research encompasses a broad range of topics primarily centered on cancer detection, management, and immunotherapy.

The scientist's work covers several key topics including:

  • Cutaneous Melanoma Detection and Management
  • Nonmelanoma Skin Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Cutaneous lymphoproliferative disorders research
  • Melanoma and MAPK Pathways
  • CAR-T cell therapy research

Berking has collaborated frequently with other researchers in the field, including:

  • Markus V. Heppt (111 collaborations)
  • Theresa Steeb (71 collaborations)
  • Dirk Schadendorf (59 collaborations)
  • Friedegund Meier (56 collaborations)
  • Ralf Gutzmer (55 collaborations)

Their research has been published primarily in venues such as:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft (34 publications)
  • European Journal of Cancer (18 publications)
  • Cancers (13 publications)
  • Journal of the European Academy of Dermatology and Venereology (11 publications)
  • International Journal of Molecular Sciences (10 publications)

Some of the recent publications by Carola Berking include:

  • "Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial", 2020, The Lancet Oncology
  • "Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial", 2021, The Lancet Oncology
  • "Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial", 2020, The Lancet
  • "Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts", 2021, European Journal of Cancer
  • "SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases", 2021, Annals of the Rheumatic Diseases

Best Publications

  • The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

    Eliezer M. Van Allen;Eliezer M. Van Allen;Nikhil Wagle;Nikhil Wagle;Antje Sucker;Daniel J. Treacy

  • Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.

    Dmitri Lodygin;Valery Tarasov;Alexey Epanchintsev;Carola Berking

  • MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

    Paolo A. Ascierto;Dirk Schadendorf;Carola Berking;Sanjiv S. Agarwala

  • Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

    Ulrike Leiter;Rudolf Stadler;Cornelia Mauch;Werner Hohenberger

  • Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy.

    Lars Hofmann;Andrea Forschner;Carmen Loquai;Simone M. Goldinger

  • Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.

    Lisa Zimmer;Simone M. Goldinger;Lars Hofmann;Carmen Loquai

  • Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

    Titus J. Brinker;Titus J. Brinker;Achim Hekler;Alexander H. Enk;Joachim Klode

  • Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.

    Benjamin Weide;Alexander Martens;Jessica C. Hassel;Carola Berking

  • Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cells

    Robert Besch;Hendrik Poeck;Tobias Hohenauer;Daniela Senft

  • The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

    Caroline J. Voskens;Simone M. Goldinger;Carmen Loquai;Caroline Robert

  • 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

    Poeck H;Besch R;Maihoefer C;Maihoefer C;Renn M

  • Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

    Thomas K. Eigentler;Jessica C. Hassel;Carola Berking;Jens Aberle

  • Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

    Michael R Migden;Nikhil I Khushalani;Anne Lynn S Chang;Karl D Lewis

  • Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.

    Titus Josef Brinker;Titus Josef Brinker;Achim Hekler;Jochen Sven Utikal;Jochen Sven Utikal;Niels Grabe

  • Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    Alexander M M Eggermont;Christian U Blank;Mario Mandalà;Georgina V Long

  • Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.

    Douglas B. Johnson;Alexander M. Menzies;Lisa Zimmer;Zeynep Eroglu

  • Deep neural networks are superior to dermatologists in melanoma image classification

    Titus J. Brinker;Titus J. Brinker;Achim Hekler;Alexander H. Enk;Carola Berking

  • Superior skin cancer classification by the combination of human and artificial intelligence

    Achim Hekler;Jochen S. Utikal;Jochen S. Utikal;Alexander H. Enk;Axel Hauschild

  • Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

    Richard D. Carvajal;Sophie Piperno-Neumann;Ellen Kapiteijn;Paul B. Chapman

  • A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

    Titus J. Brinker;Titus J. Brinker;Achim Hekler;Alexander H. Enk;Joachim Klode

Frequent Co-Authors

Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Thomas Ruzicka
Thomas Ruzicka Ludwig-Maximilians-Universität München
Ralf Gutzmer
Ralf Gutzmer Hannover Medical School
Jochen Utikal
Jochen Utikal German Cancer Research Center
Axel Hauschild
Axel Hauschild Kiel University
Claus Garbe
Claus Garbe University of Tübingen
Jürgen C. Becker
Jürgen C. Becker University of Duisburg-Essen
Reinhard Dummer
Reinhard Dummer University of Zurich
Alexander Enk
Alexander Enk Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the medical field doesn’t always require the traditional route of medical school. There are a variety of online degrees and career pathways that offer flexibility, practical experience, and a strong demand in the job market. For those without a nursing background, online bsn programs for non nurses provide a direct path to becoming a registered nurse and entering healthcare roles quickly.

Not everyone is seeking a clinical position; some may prefer administrative roles. Accredited medical billing and coding schools that accept financial aid are a great option for students interested in the business side of medicine. These programs often have flexible schedules and are affordable, opening doors for individuals to join healthcare through technical expertise.

Fast-track opportunities also exist for those who want to become practical nurses. Look for an lpn program no entrance exam to start working in the healthcare field sooner, especially if you want to avoid lengthy admission processes.

If leadership or operations is your goal, healthcare administration degrees can lead to roles in hospital management, policy, and administration. Each of these pathways provides unique opportunities for building a meaningful healthcare career online.

Best Scientists Citing Carola Berking

Trending Scientists